Responses of dural mast cells in concussive and blast models of mild traumatic brain injury in mice: Potential implications for post-traumatic headache

Cephalalgia

Volumn 36, Issue 10, 2016, Pages 915-923

  Levy, Dan ^a,b   Edut, Shahaf ^c   Baraz Goldstein, Renana ^c   Rubovitch, Vardit ^c   Defrin, Ruth ^c   Bree, Dara ^a,b   Gariepy, Helaine ^a,b   Zhao, Jun ^a,b   Pick, Chaim G ^c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

blast; concussion; dura; mast cell; Minimal traumatic brain injury; mouse; posttraumatic headache

Indexed keywords

CROMOGLYCATE DISODIUM; SUMATRIPTAN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CONCUSSION; CELL ACTIVATION; CONTROLLED STUDY; DURA MATER; HISTOCHEMISTRY; MALE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; POSTTRAUMATIC HEADACHE; TRAUMATIC BRAIN INJURY; ANIMAL; BLAST INJURY; COMPLICATION; DEGRANULATION; INSTITUTE FOR CANCER RESEARCH MOUSE; MAST CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; POST-TRAUMATIC HEADACHE;

ANIMALS; BLAST INJURIES; BRAIN CONCUSSION; CELL DEGRANULATION; DURA MATER; MALE; MAST CELLS; MICE; MICE, INBRED ICR; POST-TRAUMATIC HEADACHE;

EID: 84983036816     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102415617412     Document Type: Article

References (35)

1. Gardner RC, Yaffe K,. Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci 2015; 66 (Pt B): 75-80.
2. Keidel M, Ramadan N, Acute post traumatic headache. In: Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, (eds). The Headaches, 3rd edn. Philadelphia: Lippincott, Willimas & Wilkins, 2006, pp. 863-872.
3. Nampiaparampil DE,. Prevalence of chronic pain after traumatic brain injury: a systematic review. JAMA 2008; 300 (6): 711-719.
4. Lucas S,. Posttraumatic Headache: Clinical Characterization and Management. Curr Pain Headache Rep 2015; 19 (10): 520-520.
5. DiTommaso C, Hoffman JM, Lucas S, et al. Medication usage patterns for headache treatment after mild traumatic brain injury. Headache 2014; 54 (3): 511-519.
6. Ericsson A, Arias C, Sawchenko PE,. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 1997; 17 (18): 7166-7179.
7. Lucas S, Hoffman JM, Bell KR, et al. Characterization of headache after traumatic brain injury. Cephalalgia 2012; 32 (8): 600-606.
8. Walker WC, Marwitz JH, Wilk AR, et al. Prediction of headache severity (density and functional impact) after traumatic brain injury: A longitudinal multicenter study. Cephalalgia 2013; 33 (12): 998-1008.
9. Olesen J, Burstein R, Ashina M, et al. Origin of pain in migraine: evidence for peripheral sensitisation. Lancet Neurol 2009; 8 (7): 679-90.
10. Levy D, Strassman AM, Burstein R,. A critical view on the role of migraine triggers in the genesis of migraine pain. Headache 2009; 49 (6): 953-957.
11. Messlinger K,. Migraine: where and how does the pain originate? Exp Brain Res 2009; 196 (1): 179-193.
12. Levy D, Burstein R, Kainz V, et al. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 2007; 130 (1-2): 166-176.
13. Benromano T, Defrin R, Ahn AH, et al. Mild closed head injury promotes a selective trigeminal hypernociception: Implications for the acute emergence of post-traumatic headache. Eur J Pain 2014; 19 (5): 621-628.
14. Stokely ME, Orr EL,. Acute effects of calvarial damage on dural mast cells, pial vascular permeability, and cerebral cortical histamine levels in rats and mice. J Neurotrauma 2008; 25 (1): 52-61.
15. Roth TL, Nayak D, Atanasijevic T, et al. Transcranial amelioration of inflammation and cell death after brain injury. Nature 2014; 505 (7482): 223-228.
16. Theeler BJ, Flynn FG, Erickson JC,. Headaches after concussion in US soldiers returning from Iraq or Afghanistan. Headache 2010; 50 (8): 1262-1272.
17. Rubovitch V, Ten-Bosch M, Zohar O, et al. A mouse model of blast-induced mild traumatic brain injury. Exp Neurol 2011; 232 (2): 280-289.
18. Buzzi MG, Moskowitz MA,. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99 (1): 202-206.
19. Pedersen SH, Ramachandran R, Amrutkar DV, et al. Mechanisms of glyceryl trinitrate provoked mast cell degranulation. Cephalalgia 2015; 35 (14): 1287-1297.
20. Zhang T, Finn DF, Barlow JW, et al. Mast cell stabilisers. Eur J Pharmacol Epub ahead of print 27 June 2015. DOI: 10.1016/j.ejphar.2015.05.071.
21. Zohar O, Schreiber S, Getslev V, et al. Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 2003; 118 (4): 949-955.
22. Leder LD,. The chloroacetate esterase reaction. A useful means of histological diagnosis of hematological disorders from paraffin sections of skin. Am J Dermatopathol 1979; 1 (1): 39-42.
23. Humphries DE, Wong GW, Friend DS, et al. Heparin is essential for the storage of specific granule proteases in mast cells. Nature 1999; 400 (6746): 769-772.
24. Bankova LG, Lezcano C, Pejler G, et al. Mouse mast cell proteases 4 and 5 mediate epidermal injury through disruption of tight junctions. J Immunol 2014; 192 (6): 2812-2820.
25. Milman A, Rosenberg A, Weizman R, et al. Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma 2005; 22 (9): 1003-1010.
26. Shimada R, Nakao K, Furutani R, et al. A rat model of changes in dural mast cells and brain histamine receptor H3 expression following traumatic brain injury. J Clin Neurosci 2012; 19 (3): 447-451.
27. Tashlykov V, Katz Y, Volkov A, et al. Minimal traumatic brain injury induce apoptotic cell death in mice. J Mol Neurosci 2009; 37 (1): 16-24.
28. Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science 2013; 339 (6123): 1092-1095.
29. Hendrix S, Kramer P, Pehl D, et al. Mast cells protect from post-traumatic brain inflammation by the mast cell-specific chymase mouse mast cell protease-4. FASEB J 2013; 27 (3): 920-929.
30. Zhang X, Strassman AM, Burstein R, et al. Sensitization and activation of intracranial meningeal nociceptors by mast cell mediators. J Pharmacol Exp Ther 2007; 322 (2): 806-812.
31. Russo AF,. Calcitonin gene-related peptide (CGRP): a new target for migraine. Annu Rev Pharmacol Toxicol 2015; 55: 533-552.
32. Buzzi MG, Dimitriadou V, Theoharides TC, et al. 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 1992; 583 (1-2): 137-149.
33. Levy D, Jakubowski M, Burstein R,. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci USA 2004; 101 (12): 4274-4279.
34. Defrin R, Riabinin M, Feingold Y, et al. Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism. J Neurotrauma 2015; 32 (1): 28-37.
35. Defrin R, Gruener H, Schreiber S, et al. Quantitative somatosensory testing of subjects with chronic post-traumatic headache: implications on its mechanisms. Eur J Pain 2010; 14 (9): 924-931.